Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy-Reference-Cited by-同舟云学术

Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy

Published:2020-11-01 Issue:11 Volume:77 Page:1408
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Brendel Matthias¹,Barthel Henryk²,van Eimeren Thilo³⁴⁵,Marek Ken⁶⁷,Beyer Leonie¹,Song Mengmeng¹,Palleis Carla⁸,Gehmeyr Mona⁸,Fietzek Urban⁸,Respondek Gesine⁹,Sauerbeck Julia¹,Nitschmann Alexander¹,Zach Christian¹,Hammes Jochen³,Barbe Michael T.⁴,Onur Oezguer⁴,Jessen Frank⁵¹⁰¹¹,Saur Dorothee¹²,Schroeter Matthias L.¹³¹⁴¹⁵,Rumpf Jost-Julian¹²,Rullmann Michael²,Schildan Andreas²,Patt Marianne²,Neumaier Bernd³¹⁶,Barret Olivier⁶⁷,Madonia Jennifer⁶⁷,Russell David S.⁶⁷,Stephens Andrew¹⁷,Roeber Sigrun¹⁸,Herms Jochen¹⁸¹⁹,Bötzel Kai⁸,Classen Joseph¹²,Bartenstein Peter¹²⁰,Villemagne Victor²¹²²,Levin Johannes⁸¹⁹,Höglinger Günter U.⁹¹⁹²⁰²³,Drzezga Alexander³⁵¹⁶,Seibyl John⁶⁷,Sabri Osama²

Affiliation:

1. Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany

2. Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany

3. Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany

4. Department of Neurology, University Hospital Cologne, Cologne, Germany

5. German Center for Neurodegenerative Diseases (DZNE), Bonn-Cologne, Germany

6. InviCRO LLC, Boston, Massachusetts

7. Molecular Neuroimaging, A Division of InviCRO, New Haven, Connecticut

8. Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany

9. Department of Neurology, Hannover Medical School, Hannover, Germany

10. Department of Psychiatry, University Hospital Cologne, Cologne, Germany

11. Center for Memory Disorders, University Hospital Cologne, Cologne, Germany

12. Department of Neurology, University of Leipzig, Leipzig, Germany

13. Clinic for Cognitive Neurology, University of Leipzig, Leipzig, Germany

14. LIFE–Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany

15. Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany

16. Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, Nuclear Chemistry (INM-5), Jülich, Germany

17. Life Molecular Imaging GmbH, Berlin, Germany

18. Center for Neuropathology and Prion Research, University Hospital of Munich, LMU Munich, Munich, Germany

19. German Center for Neurodegenerative Diseases (DZNE), Munich, Germany

20. Munich Cluster for Systems Neurology (SyNergy), Munich, Germany

21. Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, Victoria, Australia

22. Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia

23. Department of Neurology, Technical University Munich, Munich, Germany

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2768084/jamaneurology_brendel_2020_oi_200052_1604530423.63592.pdf

Reference29 articles.

1. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia.;Steele;Arch Neurol,1964

2. Four-repeat tauopathies.;Rösler;Prog Neurobiol,2019

3. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.;Williams;Lancet Neurol,2009

4. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.;Boxer;Lancet Neurol,2017

5. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria.;Höglinger;Mov Disord,2017

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of PET tracers for the early diagnosis of Alzheimer's disease;TrAC Trends in Analytical Chemistry;2024-03

2. One-Year Longitudinal Changes in Tau Accumulation on [¹⁸F]PI-2620 PET in the Alzheimer Spectrum;Journal of Nuclear Medicine;2024-02-01

3. Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases;Acta Neuropathologica;2024-01-27

4. Neuronal intranuclear inclusion disease with cerebellar white matter tau uptake and incidental meningioma;European Journal of Nuclear Medicine and Molecular Imaging;2024-01-26

5. Association of Neurofilament Light Chain, [ ¹⁸ F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid–Negative CBS;Neurology;2024-01-09